Antimicrobial Susceptibility Test Market

Antimicrobial Susceptibility Test Market Outlook (2022-2032)

The global antimicrobial susceptibility test market is set to enjoy a valuation of US$ 3,285.8 Million in 2022 and further expand at a CAGR of 5.7% to reach US$ 5,712.2 Million by the end of 2032.

Kits, Reagents & Consumables segment leads the antimicrobial susceptibility test market and is expected to contribute more than 58% of the global market growth over the assessment period.

Report Attributes	Details
Antimicrobial Susceptibility Test Market Size (2021A)	US$ 3,138.6 Million
Estimated Market Value (2022E)	US$ 3,285.8 Million
Forecasted Market Value (2032F)	US$ 5,712.2 Million
Global Market Growth Rate (2022-2032)	5.7% CAGR
North America Market Share (2021)	~34.9%
East Asia Market Growth Rate (2022-2032)	~4.7% CAGR
United States Market Growth Rate (2022-2032)	~4.7% CAGR
Market Share of Top 5 Companies	~23.6%
Key Companies Profiled	Bio-Rad Laboratories, Inc. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) Thermo Fisher Scientific, Inc. Becton, Dickinson and Company Conda Creative Diagnostics HiMedia Laboratories Alifax Holding S.p.A. Biotron Healthcare

Sales Analysis of Antimicrobial Susceptibility Test (2017-2021) Vs. Market Forecast Outlook (2022-2032)

The global market for antimicrobial susceptibility expanded at a CAGR of 4.1% over the last five years (2017-2021).

The goal of antimicrobial susceptibility testing (AST), a laboratory process carried out by medical technologists, is to determine which antimicrobial regimen will work best for a certain patient. Continuous research activities are being conducted because bacteria, pathogens, and other disease-spreading organisms are always evolving. As a result, the demand for antimicrobial susceptibility tests has been increased from the past few years. All of the aforementioned elements have helped the target market grow favorably over time.

Additionally, antimicrobial susceptibility test producers also continuously improve their goods to give their customers the most dependable products possible. For instance, ThermoFisher Scientific, one of the top producers of lab equipment and life science solutions, offers a variety of antimicrobial susceptibility testers, including automatic, manual, and other models. As a result, there will likely be an increase in the demand for antimicrobial susceptibility test over the course of the forecast period. These testers are used to conduct antimicrobial susceptibility tests, which allow researchers to learn how specific antimicrobials react when treating particular infections brought on by bacteria or fungi.

Fact.MR suggests that the global antimicrobial susceptibility test market will be valued at US$ 5,712.2 Mn by 2032 end posing a CAGR of 5.7% since 2022.

• Short Term (2022 Q2 to 2025): Rising outbreaks of infectious diseases such as salmonella serotype typhi, shigella etc. will favorably affect the market growth of antimicrobial susceptibility test.
• Medium Term (2025-2028): Growing emphasis on drug discovery and increasing incidences of chronic disorders and of antimicrobial resistance will propel the market growth of antimicrobial susceptibility test in the later forecast years.
• Long Term (2028-2032): Entrance of lead global healthcare sector manufacturers in the market will dictate the long term growth of antimicrobial susceptibility test market across different regions.

Over the 2017-2021 historical period, the global antimicrobial susceptibility test market registered a CAGR of 4.1%, and according to the Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at 5.7% CAGR between 2022 and 2032.

Market share analysis of Antimicrobial susceptibility test based on products and region is provided in a nutshell in the above image. Under the product segment, the kits, reagents, & consumables segment dominates with 55.6% market share in 2022.

What’s Driving Demand for Antimicrobial Susceptibility Test?

“Rising Microbial Resistance to Drive the Demand of Antimicrobial Susceptibility Tests”

Antimicrobial susceptibility testing is becoming more and more popular as a result of rising microbial resistance, which is boosting the size of the global market. People of all ages and races are impacted by the complex issue of antimicrobial resistance.

According to Fact.MR data, antimicrobial resistance causes approximately 2 million infections and 23,000 fatalities annually in the United States, as well as an estimated 25,000 deaths from antibacterial-resistant diseases in Europe. Thus, there is a growing need for novel broad spectrum antibacterial medications.

Additionally, government funding and attention are two more important factors influencing the development of the target product. For instance, the WHO and other non-profit funding organisations proposed a new antimicrobial innovation funding mechanism, in which the government would finance grants and innovation-induced rewards that would benefit upstream innovation, interim trial findings, as well as the outcomes of the finished product.

“Increasing Number of Infectious Diseases Caused by Bacteria and Fungus to Maintain Growth Trajectory of Antimicrobial Susceptibility Test”

The rising incidence of infectious diseases brought on by bacteria and fungus is one of the main drivers of the antimicrobial susceptibility tests market's expansion. Antimicrobial susceptibility tests are used to examine susceptibility in order to administer adequate antimicrobial treatment to patients without any side effects. Additionally, assays for antimicrobial susceptibility are available for a number of testing techniques, including antibacterial, antifungal, and other susceptible testing methods.

Antimicrobial susceptibility testing is being more widely used in clinical diagnosis, medication development, and other therapeutic applications. These are a few of the major driving forces behind the market for antimicrobial susceptibility tests.

What Do Antimicrobial Susceptibility Test Manufacture Need to Watch Out for?

“The Tight Regulatory Framework Could Hamper the Market Growth”

Tools for assessing an antimicrobial susceptibility that are automated are expensive as they have many intricate features and capabilities. This issue is a significant barrier to their broad adoption by end users, especially smaller medical facilities.

Additionally, enterprises in the market face scientific and regulatory difficulties that increase development costs and lengthen the time to market, which jeopardizes the marketability of the product. Tight regulatory government regulations and the challenges associated with antimicrobial susceptibility testing are anticipated to constrain the industry.

Country-wise Insights

Will the Growing Adoption of Antimicrobial Susceptibility Testing in North America to Drive the Market Growth?

The antimicrobial susceptibility test market share in North America is expected to reach at a CAGR of 6.0% over 2022 to 2032.

The market is expanding in North America due to increasing demand for antimicrobial susceptibility testing to support empiric treatment, rising research and development activities for antimicrobial resistance testing systems, and growing adoption of antimicrobial susceptibility testing in a medical laboratory.

Furthermore, the majority of well-known firms have their headquarters here. Major players have focused on growth to increase their network and capabilities. These elements are fueling market growth all over the continent.

What is the Demand Outlook of Antimicrobial Susceptibility Test in Europe?

Europe market accounted for 31.1% of global antimicrobial susceptibility test market at the end of 2021.

The antimicrobial susceptibility testing market in Europe offers significant growth potential as a result of the region's improved healthcare infrastructure, rising unmet medical demands, and rising antibiotic resistance rates among its population. The market growth in the region is also predicted to be boosted by government efforts and health insurance policies.

In addition, the region's market for worldwide antimicrobial susceptibility testing is expanding as a result of increased awareness of infectious diseases and the growing need to control them.

Category-wise Insights

Which Antimicrobial Susceptibility Test Product to Gain Traction?

Disk diffusion method hold the largest market share of 28.4% amongst all products by 2022.

Regarding the antimicrobial drugs that can be examined, the disc diffusion method is one of the most adaptable susceptibility testing techniques. The demand for the target product is being driven by the increasing acceptance of disc diffusion and advancements in susceptibility plates.

Additionally, disc diffusion has numerous benefits since it is affordable, adaptable, and allows for the visibility of development, the proper inoculum, mixed cultures, and other anomalies. As a result, it holds the largest market share among the other products of antimicrobial susceptibility test.

Will Market Growth Be Led by Diagnostic Laboratories and Hospitals?

Due to the extensive use of the most recent technology in diagnostic laboratories and hospitals for antimicrobial susceptibility testing, these sub segment are expected to control the market. Testing for antibiotic susceptibility is helpful in evaluating hospital-based medical treatments.

Furthermore, during the forecast period, there will likely be an increase in demand for target product in diagnostic laboratories and hospitals due to rising actions of government for the global development of high-quality hospital set-up and rising susceptibility to infectious diseases.

Competitive Landscape

Prominent Antimicrobial susceptibility test manufacturers are Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Conda, Creative Diagnostics, HiMedia Laboratories, Alifax Holding S.p.A., Biotron Healthcare.

The leading companies in the global antimicrobial susceptibility test market are involved in product launches, regulatory approvals, technologically enhanced products, acquisitions, and joint ventures with other enterprises. These strategies are probably going to boost the global market for antibiotic susceptibility tests.

• In Apr 2022, bioMérieux acquire specific diagnostics. This will help the company to strengthen its commitment to fight antimicrobial resistance.
• In Aug 2022, BD, a leading global medical technology company, announced worldwide commercial collaboration with Accelerate Diagnostics, Inc. which will help both the companies to address the global threat of antimicrobial resistance.

Fact.MR has provided detailed information about the price points of key manufacturers of Antimicrobial susceptibility test positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Antimicrobial Susceptibility Test Industry Research

• By Product :

  • Kits, Reagents, & Consumables
  • Automated Test Systems
  • Culture Media

• By Method :

  • Broth Dilution Method
  • Rapid Automated Method
  • Disk Diffusion Method
  • Gradient Diffusion Method
  • Molecular Testing Method

• By Test Type :

  • Antibacterial
  • Anti-parasitic
  • Antifungal
  • Others

• By Application .

  • Clinical Diagnosis
  • Drug Discovery and Development
  • Others

• By End-user :

  • Diagnostic Laboratories and Hospitals
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & ASEAN
  • Oceania
  • MEA